Patient Journey and Segmentation in Niche Diseases

We first presented this case study at the 2022 PMSA Annual Conference.

This case study demonstrated a novel approach to capturing deidentified patient clinical data (equivalent to EHR data) in multiple countries. The case study describes the application of over-sampling to ensure analytical integrity for small sub-cohorts of patients. In this case the sub-cohorts referred to genotypes relevant in diagnosing NASH.

If you would like more details regarding this white paper, or to discuss your own data needs please contact us at

Download this White Paper: Patient Journey and Segmentation in Niche Diseases (PDF, 451 KB)

About the Author

Simon Fitall

Simon is the CEO of Tudor Health. Specialist in knowledge management with specific interest in longitudinal patient data, data capture and analysis techniques, as well as the assessment and evaluation of IP in pharma and biotech – including all stages of drug development from discovery to death of the product.

More News & Insights

Understanding Health Equity Let’s explore the significance of health equity and why it has become a major focus for healthcare companies worldwide. We will also discuss the concept of Diversity, […]


Tudor Health is delighted to announce that data scientist John Elhagar has joined our growing team. With his arrival, we are excited to welcome fresh energy and expertise, propelling Tudor […]



Share this Page